Cognition Therapeutics Statistics
Share Statistics
Cognition Therapeutics has 61.99M
shares outstanding. The number of shares has increased by 54.71%
in one year.
| Shares Outstanding | 61.99M |
| Shares Change (YoY) | 54.71% |
| Shares Change (QoQ) | 49.16% |
| Owned by Institutions (%) | 27.39% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 12,435 |
| FTD / Avg. Volume | 0.85% |
Short Selling Information
The latest short interest is 912.9K, so 1.47% of the outstanding
shares have been sold short.
| Short Interest | 912.9K |
| Short % of Shares Out | 1.47% |
| Short % of Float | 1.64% |
| Short Ratio (days to cover) | 2.42 |
Valuation Ratios
The PE ratio is -0.82 and the forward
PE ratio is -0.34.
Cognition Therapeutics's PEG ratio is
0.
| PE Ratio | -0.82 |
| Forward PE | -0.34 |
| PS Ratio | 0 |
| Forward PS | 0.2 |
| PB Ratio | 1.49 |
| P/FCF Ratio | -0.98 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Cognition Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65,
with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.65 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.03 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,358,840 |
| Employee Count | 25 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -83.08% in the
last 52 weeks. The beta is 0.99, so Cognition Therapeutics's
price volatility has been higher than the market average.
| Beta | 0.99 |
| 52-Week Price Change | -83.08% |
| 50-Day Moving Average | 0.4 |
| 200-Day Moving Average | 0.54 |
| Relative Strength Index (RSI) | 39.87 |
| Average Volume (20 Days) | 1,469,873 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -53.97M |
| Net Income | -33.97M |
| EBITDA | -33.68M |
| EBIT | -34M |
| Earnings Per Share (EPS) | -0.86 |
Full Income StatementBalance Sheet
The company has 25.01M in cash and 814K in
debt, giving a net cash position of 24.2M.
| Cash & Cash Equivalents | 25.01M |
| Total Debt | 814K |
| Net Cash | 24.2M |
| Retained Earnings | -175.16M |
| Total Assets | 30.23M |
| Working Capital | 18.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -28.47M
and capital expenditures -4K, giving a free cash flow of -28.48M.
| Operating Cash Flow | -28.47M |
| Capital Expenditures | -4K |
| Free Cash Flow | -28.48M |
| FCF Per Share | -0.72 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
